Buscaline
The issue of Buscaline is a topic that has generated great interest and controversy in recent times. With different approaches and perspectives, Buscaline has been the subject of debate and research in various areas of knowledge. From its impact on society to its implications at the individual level, Buscaline has captured the attention of academics, specialists and ordinary people. In this article, we will explore different aspects related to Buscaline, analyzing its relevance and unraveling its possible consequences. Additionally, we will examine how Buscaline has shaped and will continue to shape the current landscape, offering a comprehensive view of this important topic.
 | This article relies largely or entirely on a single source. (August 2019) |
| |
| |
| Names | |
|---|---|
| Preferred IUPAC name
2-(3,5-Dimethoxy-4-butoxyphenyl)ethan-1-amine | |
| Other names
3,5-Dimethoxy-4-butoxyphenethylamine
2-(4-Butoxy-3,5-dimethoxy-phenyl)-ethylamine | |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C14H23NO3 | |
| Molar mass | 253.342 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
| |
Buscaline (3,5-dimethoxy-4-butoxyphenethylamine) is a chemical compound prepared as a possible psychedelic drug. It is an analog of mescaline. Buscaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 150 mg, and the duration is "several hours". Buscaline produces no psychedelic or psychoactive effects, but causes heart arrythmia and light diarrhea. It does not cause any visuals or insights. Very little data exists about the pharmacological properties, metabolism, and toxicity of buscaline.
See also
External links
References
 | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |